News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,079 Results
Type
Article (44896)
Company Profile (325)
Press Release (692858)
Multimedia
Podcasts (100)
Webinars (14)
Section
Business (214995)
Career Advice (2244)
Deals (37455)
Drug Delivery (120)
Drug Development (84400)
Employer Resources (177)
FDA (16980)
Job Trends (15843)
News (363683)
Policy (34753)
Tag
Academia (2688)
Accelerated approval (6)
Adcomms (27)
Allergies (94)
Alliances (53020)
ALS (102)
Alzheimer's disease (1435)
Antibody-drug conjugate (ADC) (154)
Approvals (16956)
Artificial intelligence (300)
Autoimmune disease (27)
Automation (17)
Bankruptcy (378)
Best Places to Work (12067)
BIOSECURE Act (21)
Biosimilars (118)
Biotechnology (202)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (311)
Cancer (2455)
Cardiovascular disease (202)
Career advice (1872)
Career pathing (33)
CAR-T (172)
Cell therapy (470)
Cervical cancer (20)
Clinical research (68760)
Collaboration (930)
Company closure (2)
Compensation (593)
Complete response letters (28)
COVID-19 (2714)
CRISPR (52)
C-suite (268)
Cystic fibrosis (106)
Data (2440)
Decentralized trials (2)
Denatured (31)
Depression (49)
Diabetes (296)
Diagnostics (6657)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (128)
Drug pricing (130)
Drug shortages (32)
Duchenne muscular dystrophy (104)
Earnings (90179)
Editorial (44)
Employer branding (21)
Employer resources (152)
Events (118730)
Executive appointments (792)
FDA (18436)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (824)
Gene editing (125)
Generative AI (26)
Gene therapy (360)
GLP-1 (821)
Government (4671)
Grass and pollen (5)
Guidances (174)
Healthcare (19582)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (31)
Infectious disease (2872)
Inflammatory bowel disease (150)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (102)
Interviews (355)
IPO (17107)
IRA (48)
Job creations (4199)
Job search strategy (1589)
Kidney cancer (11)
Labor market (43)
Layoffs (520)
Leadership (24)
Legal (8598)
Liver cancer (77)
Lung cancer (343)
Lymphoma (168)
Machine learning (9)
Management (61)
Manufacturing (365)
MASH (85)
Medical device (13957)
Medtech (13962)
Mergers & acquisitions (20955)
Metabolic disorders (798)
Multiple sclerosis (90)
NASH (20)
Neurodegenerative disease (112)
Neuropsychiatric disorders (34)
Neuroscience (2049)
NextGen: Class of 2025 (6909)
Non-profit (4624)
Now hiring (41)
Obesity (429)
Opinion (254)
Ovarian cancer (84)
Pain (104)
Pancreatic cancer (89)
Parkinson's disease (166)
Partnered (22)
Patents (263)
Patient recruitment (121)
Peanut (50)
People (60611)
Pharmaceutical (99)
Pharmacy benefit managers (24)
Phase I (21444)
Phase II (30205)
Phase III (22611)
Pipeline (1501)
Policy (176)
Postmarket research (2691)
Preclinical (9084)
Press Release (69)
Prostate cancer (112)
Psychedelics (31)
Radiopharmaceuticals (257)
Rare diseases (425)
Real estate (6456)
Recruiting (67)
Regulatory (23770)
Reports (50)
Research institute (2439)
Resumes & cover letters (381)
Rett syndrome (7)
RNA editing (8)
RSV (48)
Schizophrenia (81)
Series A (142)
Series B (97)
Service/supplier (18)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (154)
Sponsored (34)
Startups (3835)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (59)
The Weekly (67)
Vaccines (747)
Venture capitalists (43)
Weight loss (294)
Women's health (37)
Worklife (18)
Date
Today (24)
Last 7 days (911)
Last 30 days (3521)
Last 365 days (33644)
2025 (13138)
2024 (36525)
2023 (41311)
2022 (52568)
2021 (57215)
2020 (55883)
2019 (48798)
2018 (36940)
2017 (34026)
2016 (33725)
2015 (39571)
2014 (33455)
2013 (28528)
2012 (30644)
2011 (31310)
2010 (29286)
Location
Africa (825)
Alabama (55)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (42432)
Australia (6725)
California (6714)
Canada (2140)
China (580)
Colorado (289)
Connecticut (292)
Delaware (168)
Europe (91697)
Florida (1003)
Georgia (231)
Idaho (62)
Illinois (598)
India (27)
Indiana (341)
Iowa (12)
Japan (183)
Kansas (108)
Kentucky (26)
Louisiana (13)
Maine (63)
Maryland (960)
Massachusetts (5041)
Michigan (251)
Minnesota (423)
Mississippi (2)
Missouri (90)
Montana (27)
Nebraska (25)
Nevada (72)
New Hampshire (64)
New Jersey (1872)
New Mexico (31)
New York (1887)
North Carolina (1075)
North Dakota (9)
Northern California (2943)
Ohio (223)
Oklahoma (15)
Oregon (40)
Pennsylvania (1472)
Puerto Rico (14)
Rhode Island (35)
South America (1215)
South Carolina (28)
South Dakota (1)
Southern California (2508)
Tennessee (110)
Texas (1002)
United States (25307)
Utah (198)
Virginia (170)
Washington D.C. (70)
Washington State (594)
West Virginia (3)
Wisconsin (71)
738,079 Results for "catalent pharma solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors
May 15, 2025
·
3 min read
Press Releases
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
April 28, 2025
·
2 min read
Editorial
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’
The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo Nordisk Foundation, one of the world’s largest charitable foundations.
October 24, 2024
·
6 min read
·
Jef Akst
Tariffs
Trump Opens National Security Probe on Pharma Imports, Signaling Imminent Tariffs
Trump could use the findings of the probe to impose certain trade restrictions on pharma products, including tariffs.
April 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Catalent Announces New Board Appointments
February 20, 2025
·
4 min read
Press Releases
Lisata Therapeutics Announces Research License with Catalent
April 15, 2025
·
7 min read
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
May 7, 2025
·
8 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Business
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024.
May 8, 2024
·
32 min read
1 of 73,808
Next
